Through
4/26
Researchers at Penn Medicine have demonstrated a new potential treatment using CAR T cell therapy using a CRISPR base-editing to develop a method called “epitope editing.”
For third-year Olivia Kim, a PURM research experience with Penn neuroscientist Anjan Chatterjee allowed her to combine her love of neuroscience and art in a working lab.
In a new collaborative study, PIK Professor Michael Platt models how the decision-making process unfolds in the brains of buyers and sellers considering a deal. These decisions were observable in eye movements and pupil dilation.
In a Q & A, June, the Richard W. Vague Professor in Immunotherapy, and Daniel Baker, a fourth-year doctoral student in Penn’s Cell and Molecular Biology department, discuss how the treatment can extend to treating diseases beyond cancer.
Penn Medicine’s Maayan Levy and Christoph Thaiss, both assistant professors of microbiology, pursue an understanding of the the microbiome, the entirety of microbial organisms associated with the human body, and its relation to fundamental bodily systems.
Marrying artificial intelligence with advanced experimental methods, Penn Engineering’s Machine Biology Group has mined the ancient past for future medical breakthroughs, bringing extinct molecules back to life.
Researchers have developed a platform that could rapidly accelerate the development of mRNA-based lipid nanoparticle vaccines and therapeutics at both the small and largescale, SCALAR.
Katalin Karikó and Drew Weissman’s key mRNA discoveries more than 15 years earlier made COVID vaccines possible. Now the global public has opportunities to honor them.
Ahead of the arrival of students, summer on campus bustles with construction teams advancing various building projects and maintenance work. Here, a look at what’s happening now.
Through the PURM internship program, undergraduate students are further researching an algorithm developed to group kidney donor-recipient pairs into low-risk and high-risk groups for graft survival.
According to Aditi Vasan of the Leonard Davis Institute and Perelman School of Medicine, evidence is mounting in favor of the model of training community health workers to help their neighbors connect to government and health care services.
FULL STORY →
According to Thomas Wadden of the Perelman School of Medicine, people taking GLP-1 drugs are finding that daily experiences that used to trigger a compulsion to eat or think about food no longer have that effect.
FULL STORY →
PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one.
FULL STORY →
Shoshana Aronowitz of the School of Nursing and Ashish Thakrar of the Perelman School of Medicine comment on the lack of specificity in Philadelphia’s plan to remove drug users from Kensington and on the current state of drug treatment in the city.
FULL STORY →
The Hospital of the University of Pennsylvania has been named one of the most recommended acute-care facilities by patients in the Philadelphia area.
FULL STORY →